EANM Procedural Guidelines for PET/CT Quantitative Myocardial Perfusion Imaging

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2020 Nov 2

PMID 33135093

Citations 48

Authors

Roberto Sciagra

Mark Lubberink

Fabien Hyafil

Antti Saraste

Riemer H J A Slart

Denis Agostini

Carmela Nappi

Panagiotis Georgoulias

Jan Bucerius

Christoph Rischpler

Hein J Verberne

Affiliations

Soon will be listed here.

Abstract

The use of cardiac PET, and in particular of quantitative myocardial perfusion PET, has been growing during the last years, because scanners are becoming widely available and because several studies have convincingly demonstrated the advantages of this imaging approach. Therefore, there is a need of determining the procedural modalities for performing high-quality studies and obtaining from this demanding technique the most in terms of both measurement reliability and clinical data. Although the field is rapidly evolving, with progresses in hardware and software, and the near perspective of new tracers, the EANM Cardiovascular Committee found it reasonable and useful to expose in an updated text the state of the art of quantitative myocardial perfusion PET, in order to establish an effective use of this modality and to help implementing it on a wider basis. Together with the many steps necessary for the correct execution of quantitative measurements, the importance of a multiparametric approach and of a comprehensive and clinically useful report have been stressed.

Citing Articles

N-NH myocardial perfusion imaging with reduced scan duration: a feasibility study in the era of total-body PET/CT.

Zhang X, Xiang Z, Wang F, Pan X, Zhang Q, Wang P EJNMMI Phys. 2025; 12(1):18.

PMID: 40032742 PMC: 11876496. DOI: 10.1186/s40658-025-00729-4.

Is cardiopulmonary transit time (CPTT) measured by using dynamic rubidium cardiac PET/CT a predictor for cardiac function?.

Seige L, Zhang B, Heimer J, Spielhofer N, Popescu C, Murray K Int J Cardiovasc Imaging. 2025; 41(3):569-577.

PMID: 39953314 PMC: 11880084. DOI: 10.1007/s10554-025-03346-5.

Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.

Llamas-Esperon G, Berrios-Barcenas E, Cossio-Aranda J, Guerra-Lopez A, Magana-Serrano J, Iturralde-Torres P Arch Cardiol Mex. 2025; 94(Supl 4):1-75.

PMID: 39928711 PMC: 11824882. DOI: 10.24875/ACM.M25000098.

Positron Range Correction Helps Enhance the Image Quality of Cardiac Rb PET/CT.

Lassen M, Kertesz H, Rausch I, Panin V, Conti M, Zuehlsdorff S J Nucl Med. 2025; 66(3):466-472.

PMID: 39915127 PMC: 11876734. DOI: 10.2967/jnumed.124.267855.

Recent Progress in Myocardial Perfusion Imaging Techniques.

Jo K, Kang W Nucl Med Mol Imaging. 2024; 58(7):400-405.

PMID: 39635632 PMC: 11612050. DOI: 10.1007/s13139-024-00852-7.

References

Brunken R, Schelbert H . Positron emission tomography in clinical cardiology. Cardiol Clin. 1989; 7(3):607-29. View

Schelbert H, Phelps M, Huang S, MACDONALD N, Hansen H, Selin C . N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981; 63(6):1259-72. DOI: 10.1161/01.cir.63.6.1259. View

Krivokapich J, Smith G, Huang S, Hoffman E, Ratib O, Phelps M . 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation. 1989; 80(5):1328-37. DOI: 10.1161/01.cir.80.5.1328. View

Renaud J, Yip K, Guimond J, Trottier M, Pibarot P, Turcotte E . Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow. J Nucl Med. 2016; 58(1):103-109. DOI: 10.2967/jnumed.116.174565. View

Yamamoto M, Ficke D, Ter-Pogossian M . Experimental Assessment of the Gain Achieved by the Utilization of Time-of-Flight Information in a Positron Emission Tomograph (Super PETT I). IEEE Trans Med Imaging. 1982; 1(3):187-92. DOI: 10.1109/TMI.1982.4307571. View

Armstrong I, Tonge C, Arumugam P . Assessing time-of-flight signal-to-noise ratio gains within the myocardium and subsequent reductions in administered activity in cardiac PET studies. J Nucl Cardiol. 2017; 26(2):405-412. DOI: 10.1007/s12350-017-0916-x. View

Suda M, Onoguchi M, Tomiyama T, Ishihara K, Takahashi N, Sakurai M . The reproducibility of time-of-flight PET and conventional PET for the quantification of myocardial blood flow and coronary flow reserve with (13)N-ammonia. J Nucl Cardiol. 2015; 23(3):457-72. DOI: 10.1007/s12350-015-0074-y. View

Hsu D, Ilan E, Peterson W, Uribe J, Lubberink M, Levin C . Studies of a Next-Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System. J Nucl Med. 2017; 58(9):1511-1518. DOI: 10.2967/jnumed.117.189514. View

Rausch I, Ruiz A, Valverde-Pascual I, Cal-Gonzalez J, Beyer T, Carrio I . Performance Evaluation of the Vereos PET/CT System According to the NEMA NU2-2012 Standard. J Nucl Med. 2018; 60(4):561-567. DOI: 10.2967/jnumed.118.215541. View

10.

van Sluis J, de Jong J, Schaar J, Noordzij W, van Snick P, Dierckx R . Performance Characteristics of the Digital Biograph Vision PET/CT System. J Nucl Med. 2019; 60(7):1031-1036. DOI: 10.2967/jnumed.118.215418. View

11.

Driessen R, van Timmeren J, Stuijfzand W, Rijnierse M, Danad I, Raijmakers P . Measurement of LV Volumes and Function Using Oxygen-15 Water-Gated PET and Comparison With CMR Imaging. JACC Cardiovasc Imaging. 2016; 9(12):1472-1474. DOI: 10.1016/j.jcmg.2016.01.014. View

12.

Schindler T, Dilsizian V . PET-determined hyperemic myocardial blood flow: further progress to clinical application. J Am Coll Cardiol. 2014; 64(14):1476-8. DOI: 10.1016/j.jacc.2014.04.086. View

13.

Iguchi S, Moriguchi T, Yamazaki M, Hori Y, Koshino K, Toyoda K . System evaluation of automated production and inhalation of O-labeled gaseous radiopharmaceuticals for the rapid O-oxygen PET examinations. EJNMMI Phys. 2018; 5(1):37. PMC: 6300454. DOI: 10.1186/s40658-018-0236-5. View

14.

Sanchez-Crespo A, Andreo P, Larsson S . Positron flight in human tissues and its influence on PET image spatial resolution. Eur J Nucl Med Mol Imaging. 2003; 31(1):44-51. DOI: 10.1007/s00259-003-1330-y. View

15.

Iida H, Rhodes C, De Silva R, Yamamoto Y, Araujo L, Maseri A . Myocardial tissue fraction--correction for partial volume effects and measure of tissue viability. J Nucl Med. 1991; 32(11):2169-75. View

16.

Yamamoto Y, De Silva R, Rhodes C, Araujo L, Iida H, Rechavia E . A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomography. Circulation. 1992; 86(1):167-78. DOI: 10.1161/01.cir.86.1.167. View

17.

Einstein A . Radiation risk from coronary artery disease imaging: how do different diagnostic tests compare?. Heart. 2008; 94(12):1519-21. DOI: 10.1136/hrt.2007.135731. View

18.

Mattsson S, Johansson L, Leide Svegborn S, Liniecki J, Nosske D, Riklund K . Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances. Ann ICRP. 2015; 44(2 Suppl):7-321. DOI: 10.1177/0146645314558019. View

19.

Selwyn A, Allan R, LAbbate A, Horlock P, Camici P, Clark J . Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. Am J Cardiol. 1982; 50(1):112-21. DOI: 10.1016/0002-9149(82)90016-9. View

20.

Goldstein R, Mullani N, Marani S, Fisher D, Gould K, OBrien Jr H . Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med. 1983; 24(10):907-15. View